Tim Schneider

1.7k total citations
72 papers, 1.4k citations indexed

About

Tim Schneider is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tim Schneider has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Urology, 19 papers in Rheumatology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tim Schneider's work include Urinary Bladder and Prostate Research (32 papers), Pelvic floor disorders treatments (18 papers) and Urinary Tract Infections Management (12 papers). Tim Schneider is often cited by papers focused on Urinary Bladder and Prostate Research (32 papers), Pelvic floor disorders treatments (18 papers) and Urinary Tract Infections Management (12 papers). Tim Schneider collaborates with scholars based in Germany, Netherlands and France. Tim Schneider's co-authors include Martin C. Michel, Charlotte Fetscher, S. Krege, Peter Hein, Steven A. Kaplan, Jean de la Rosette, Yolanda Prezado, Elfaridah P. Frazier, Μ. Goepel and Manorama Tewari and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Tim Schneider

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Schneider Germany 23 877 496 330 237 210 72 1.4k
Akihide Hirayama Japan 21 511 0.6× 344 0.7× 157 0.5× 111 0.5× 446 2.1× 100 1.2k
Alessandro Zucchi Italy 29 913 1.0× 1.1k 2.1× 202 0.6× 281 1.2× 444 2.1× 172 2.4k
Antonio Carbone Italy 25 608 0.7× 571 1.2× 205 0.6× 236 1.0× 519 2.5× 141 1.9k
R. J. Millard Australia 22 1.8k 2.0× 1.4k 2.9× 872 2.6× 80 0.3× 226 1.1× 59 2.2k
Wein Aj United States 15 1.9k 2.1× 1.6k 3.2× 1.0k 3.2× 150 0.6× 239 1.1× 33 2.3k
Caroline A. Dorrepaal Netherlands 18 637 0.7× 521 1.1× 384 1.2× 73 0.3× 287 1.4× 39 1.4k
Andersson Ke Sweden 20 343 0.4× 207 0.4× 144 0.4× 147 0.6× 117 0.6× 48 1.1k
Kristian Vinter Juul Denmark 17 286 0.3× 149 0.3× 90 0.3× 198 0.8× 305 1.5× 46 984
Margaret R. Warner United States 23 113 0.1× 92 0.2× 102 0.3× 535 2.3× 54 0.3× 60 1.8k
Stanley Sau Ching Wong Hong Kong 18 108 0.1× 88 0.2× 36 0.1× 187 0.8× 165 0.8× 64 1.0k

Countries citing papers authored by Tim Schneider

Since Specialization
Citations

This map shows the geographic impact of Tim Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Schneider more than expected).

Fields of papers citing papers by Tim Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Schneider. The network helps show where Tim Schneider may publish in the future.

Co-authorship network of co-authors of Tim Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Schneider. A scholar is included among the top collaborators of Tim Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Schneider. Tim Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, Tim, et al.. (2025). Photon mini‐GRID therapy for preoperative breast cancer tumor treatment: A treatment plan study. Medical Physics. 52(4). 2493–2506. 3 indexed citations
2.
Schneider, Tim, et al.. (2023). Correlations of mean voided volume with other parameters of overactive bladder syndrome. SHILAP Revista de lepidopterología. 5. 100577–100577. 1 indexed citations
3.
Schneider, Tim, Denis Malaise, Frédéric Pouzoulet, & Yolanda Prezado. (2023). Orthovoltage X-ray Minibeam Radiation Therapy for the Treatment of Ocular Tumours—An In Silico Evaluation. Cancers. 15(3). 679–679. 2 indexed citations
6.
Marzi, Ludovic De, C. Nauraye, P. Lansonneur, et al.. (2019). Spatial fractionation of the dose in proton therapy: Proton minibeam radiation therapy. Cancer/Radiothérapie. 23(6-7). 677–681. 14 indexed citations
7.
Michel, Martin C., et al.. (2018). Evidence-based management of overactive bladder patients: Expectation to become symptom-free. Neurourology and Urodynamics. 1 indexed citations
8.
Schneider, Tim, Christian Linz, Roman C. Brands, et al.. (2015). Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas. Clinical Oral Investigations. 20(3). 541–551. 8 indexed citations
9.
Schneider, Tim, et al.. (2014). An observational study of patient satisfaction with fesoterodine in the treatment of overactive bladder: effects of additional educational material. International Journal of Clinical Practice. 68(9). 1074–1080. 7 indexed citations
10.
Eisenhardt, A., et al.. (2014). PROPIVERINE ER AND EFFECTS OF FLEXIBLE DOSING IN 1335 PATIENTS WITH OAB: RESULTS OF A NON-INTERVENTIONAL STUDY. 1 indexed citations
11.
Wyndaele, J J, et al.. (2014). Flexible dosing with fesoterodine 4 and 8 mg: a systematic review of data from clinical trials. International Journal of Clinical Practice. 68(7). 830–840. 9 indexed citations
12.
Oelke, Matthias, et al.. (2013). Influence of propiverine ER 30 mg once daily on cognitive function in elderly female and male patients with overactive bladder: a non-interventional study to assess real life data. Neurourology and Urodynamics. 9 indexed citations
13.
Schenck, M., H. Rübben, Martin Stuschke, et al.. (2012). Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia?. World Journal of Urology. 31(2). 417–421. 8 indexed citations
15.
Igawa, Yasuhiko, Tim Schneider, Yoshinobu Yamazaki, et al.. (2012). Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(8). 759–767. 24 indexed citations
17.
Schneider, Tim, Daniela Marschall‐Kehrel, Jens Ulrich Hanisch, & M. C. Michel. (2010). Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients?. International Journal of Clinical Practice. 64(9). 1287–1293. 43 indexed citations
18.
Goldman, Howard B., Jon D. Morrow, Jason Gong, Li‐Jung Tseng, & Tim Schneider. (2010). Early onset of fesoterodine efficacy in subjects with overactive bladder. British Journal of Urology. 107(4). 598–602. 9 indexed citations
19.
Schenck, M. & Tim Schneider. (2010). Einfache und effektive Beurteilung der Anastomose nach radikaler retropubischer Prostatektomie. Der Urologe. 49(3). 364–368. 2 indexed citations
20.
Schneider, Tim & Martin C. Michel. (2010). Can [125I]-Iodocyanopindolol Label β3-Adrenoceptors in Rat Urinary Bladder?. Frontiers in Pharmacology. 1. 128–128. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026